Am J Clin Oncol
- RUNDE AP, Koo SM, Daneshpajouhnejad P, Shahid R, et al
Bytes to Blood-Artificial Intelligence in the Management of Leukemia: A 2025
Update.
Am J Clin Oncol. 2026 Mar 4. doi: 10.1097/COC.0000000000001315.
Am J Hematol
- MIZUNO S, Takami A, Kawamura K, Harada K, et al
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for
Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.
Am J Hematol. 2026 Mar 2. doi: 10.1002/ajh.70265.
Blood
- BECILLI M, Merli P, Algeri M, Del Bufalo F, et al
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for
relapsed/refractory acute myeloid leukemia.
Blood. 2026 Mar 3:blood.2025032299. doi: 10.1182/blood.2025032299.
Cancer
- LAWRENCE L
Two new options for NPM1-mutated relapsed, refractory acute myeloid leukemia:
Researchers are looking into whether revumenib or ziftomenib can be combined with
first-line standard-of-care treatment options.
Cancer. 2026;132:e70275.
Eur J Haematol
- MESSORI A
Updating Efficacy of First-Line Treatments for Chronic Lymphocytic Leukemia:
Indirect Comparisons Based on Recent Data Favor the Combination of Acalabrutinib
Plus Obinutuzumab.
Eur J Haematol. 2026 Mar 2. doi: 10.1111/ejh.70150.
J Biol Chem
- GONZALEZ-AREIZAGA G, Smithgall TE
Chaperone-assisted expression and purification of the AML-associated Src-family
kinase Fgr in Escherichia coli.
J Biol Chem. 2026;302:111099.
- CAO Q, Wang Y, Duan Y
Dynamic and extensive A-to-I RNA recoding in immunoglobulin shapes myeloid
neoplasm transcriptome.
J Biol Chem. 2026;302:111066.
Leuk Res
- WANG M, Li J
Measurable residual disease detection in acute leukemia: Technological advances
and clinical translation.
Leuk Res. 2026;163:108197.
Leukemia
- SETIAWAN T, Muhammad JA, Julianto NM, Wirawan LM, et al
Correction: Regulation of metabolic adaptation and leukemia progression by
MUSASHI2-DEPTOR-KIF11 axis.
Leukemia. 2026 Mar 5. doi: 10.1038/s41375-026-02909.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016